Cephalexin vs Clindamycin
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Cephalexin (Keflex) and clindamycin (Cleocin) are both oral antibiotics commonly prescribed for skin and soft tissue infections, though they cover different types of bacteria. Cephalexin is a first-generation cephalosporin effective against many gram-positive bacteria, while clindamycin is a lincosamide with activity against both gram-positive and anaerobic bacteria.
A key clinical difference is MRSA coverage. Clindamycin has activity against many community-acquired MRSA (methicillin-resistant Staphylococcus aureus) strains, while cephalexin does not. This makes the choice between them particularly relevant for skin infections where MRSA is suspected.
Cephalexin vs Clindamycin: Side-by-side comparison
| Category | Cephalexin | Clindamycin |
|---|---|---|
| Drug Class | Cephalosporin (1st gen) | Lincosamide |
| Brand Name | Keflex | Cleocin |
| MRSA Activity | No | Yes (many CA-MRSA strains) |
| Anaerobic Coverage | No | Yes |
| C. diff Risk | Low | Higher |
| Typical Dosing | 250-500 mg 2-4x daily | 150-450 mg 3-4x daily |
| Common Uses | Cellulitis, simple UTIs, strep throat | Skin infections, dental, bone infections |
Efficacy: How well does each drug work?
Cephalexin is highly effective for uncomplicated skin infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus species. It achieves cure rates above 90% for cellulitis and simple abscesses when the bacteria are susceptible.
Clindamycin covers a broader range of pathogens including many MRSA strains and anaerobic bacteria. IDSA guidelines recommend clindamycin as an oral option for purulent skin infections where MRSA is common locally. However, inducible clindamycin resistance (detected by D-test) can limit its usefulness in some MRSA strains.
For dental infections and certain intra-abdominal infections, clindamycin's anaerobic coverage gives it an advantage that cephalexin cannot match.
Side effects comparison
Cephalexin is generally well tolerated with mild GI side effects including nausea, diarrhea, and stomach upset in about 5-10% of patients. Allergic reactions can occur, and patients with severe penicillin allergy should use caution, though cross-reactivity with first-generation cephalosporins is low (1-2%).
Clindamycin carries a significant risk of Clostridioides difficile (C. diff) infection, a potentially severe form of antibiotic-associated diarrhea. C. diff risk is higher with clindamycin than with most other oral antibiotics. Symptoms include watery diarrhea, fever, and abdominal pain; severe cases require hospitalization.
Both antibiotics can cause rash and GI upset, but the C. diff risk with clindamycin is a meaningful safety consideration.
Cost comparison
Both cephalexin and clindamycin are available as affordable generics. Cephalexin typically costs $8-$20 for a course of treatment, and clindamycin costs $10-$30. Both are covered by most insurance plans on preferred generic tiers.
Convenience and dosing
Cephalexin is typically taken 2-4 times daily depending on the infection. Clindamycin is usually taken 3-4 times daily. Both require multi-day courses, commonly 7-10 days for skin infections.
Neither drug has significant food interactions, though taking both with food can reduce stomach upset. Clindamycin should be taken with a full glass of water to prevent esophageal irritation.
Which is right for you?
If your infection is likely caused by common streptococcal or methicillin-susceptible staph bacteria, cephalexin is an excellent first choice with a well-established safety profile and low C. diff risk.
If MRSA is suspected (purulent infection, prior MRSA history, local MRSA prevalence), clindamycin provides broader coverage. Your doctor may order a wound culture to guide the choice.
Always tell your doctor about any antibiotic allergies, particularly to penicillin or cephalosporins. Complete the full course even if you feel better before finishing.
Frequently asked questions
References
- [Observational] Cephalexin FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050405s101lbl.pdf Accessed 2026-03-01.
- [Observational] Clindamycin FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050162s092lbl.pdf Accessed 2026-03-01.
- [Observational] IDSA Guidelines for Skin and Soft Tissue Infections https://pubmed.ncbi.nlm.nih.gov/25085136/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: